Discussion
Although the complication of hypothyroidism and angina pectoris has been known for many years, therapy for such cases has been controversial.
About 60 operated cases (Nelson et al. 1974; Paine et al. 1977; Vertrees et al. 1981; Hay et al. 1981; Myerowitz et al. 1983; Levine 1980) with angina pectoris and hypothyroidism have been reported. From a review of reports of such cases, it was found that there was conspicuous hypercholesterolemia and lesions of coronary arteries were seen in the main trunk of the left coronary artery or in all thrtee major coronary arteries. These findings suggest the importance of aorto-coronary bypass surgery for the disease. Although in these cases thyroid hormone therapy is the most important treatment before and after operation, it has still remained questionable whether such therapy should be performed before cardiac catheterization or aorto-coronary bypass operation.
The untreated myxedematous patient is also prone to intraoperative cardiovascullar collapse, severe respiratory depression, infection, adynamic ileus and an inappropriate antidiuretic hormone-like syndrome (Williams, 1969) . Thus, Paine et al. (1977) have stated that these possibilities must be weighed against the real danger of myocardial infarction preoperatively when thyroid hormone therapy is begun and the possibility that the patient with myxedema and severe angina might be successfully managed with minimal thyroid replacement preoperatively with gradual but more aggressive thyroid replacement in early postoperative period. Hay et al. (1981) performed aorto-coronary bypass operation in nine patients with preoperative thyroid hormone therapy and nine cases without the therapy and reported that in both groups there were no operative complications, operative death or late death. Since myocardial infarction occurred in four patients receiving hormone therapy, they also pointed out that the lack of hormone therapy before operation would not increase operative risks, whereas thyroid hormone therapy would increase the risk of the development of myocardial infarction. Myerowitz et al. (1983) have stated that preoperative thyroid replacement therapy is, theoretically, dangerous and may not significantly improve hemodynamics until full replacement was achieved.
Coronary bypass grafting could be performed safely despite hypothyroidism with excellent early results. In fact, both Nelson et al. (1974) and Paine et al. (1977) have experienced one patient who received preoperative thyroid hormone therapy and died of ventricular fibrillation or myocardial infarction. These results suggest that a serious risk of induction of myocardial infarction with thyroid hormone therapy.
When thyroid hormone therapy is given preoperatively, it should be done under strict monitoring of the patients as was indicated by Paine et al. (1977) .
In our case, triiodothyronine was used in combination with propranolol on the understanding that the operation should be performed immediately when chest pain developed.
Despite the administration of a small dose, the electrocardiogram showed improved waves. With respect to postoperative thyroid hormone therapy, in all operated cases with or without preoperative thyroid hormone therapy, a satisfactory clinical course was maintained with thyroid hormone therapy immediately after aorto-coronary bypass surgery. Nelson et al. (1974) , however, reported complications due to depressed thyroid function that occurred in one patient who had not received thyroid hormone therapy post operatively. Thyroid hormone therapy immediately after the operation may be one of the most important factors in the postoperative recovery.
In all reported cases, there were no cases of death or episodes of chest pain when treatment of hypothyroidism was given after the operation.
Considering the many serious coronary arterial lesions associated with this disease and the successful results which may be achieved with surgical procedures, aortocoronary bypass operations are recommended for cases with angina pectoris and hypothyroidism.
Conclusion
We managed a patient with angina of effort and hypothyroidism and who received successfully aorto-coronary bypass surgery.
Reported cases of the combination diseases are discussed.
